YAP/TAZ complex is becoming a target in some cancer therapies since it has been proved that there is an increased expression of YAP and TAZ in the cell’s nucleus in KRAS-mutated cells, such as the invasive adenocarcinoma cell line MDA-MB-231. This evidence concerns the gene YAP1 and cancer.